MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis

References

• Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol. 2019;70(2):294–23. doi:10.1016/j.jhep.2018.12.003.
   PubMed Web of Science ®Google Scholar
• Gustot T, Jalan R. Acute-on-chronic liver failure in patients with alcohol-related liver disease. J Hepatol. 2019;70(2):319–327. doi:10.1016/j.jhep.2018.12.008.
   PubMed Web of Science ®Google Scholar
• Avila MA, Dufour JF, Gerbes AL, Zoulim F, Bataller R, Burra P, Cortez-Pinto H, Gao B, Gilmore I, Mathurin P. et al. Recent advances in alcohol-related liver disease (ALD): summary of a gut round table meeting. Gut. 2020;69(4):764–780. doi:10.1136/gutjnl-2019-319720.
   PubMed Web of Science ®Google Scholar
• Szabo G, Kamath PS, Shah VH, Thursz M, Mathurin P. Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study. Hepatology. 2019;69(5):2271–2283. doi:10.1002/hep.30369.
   PubMed Web of Science ®Google Scholar
• Vos T. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10262):1562–1562. doi:10.1016/s0140-6736(20)30925-9.
   Web of Science ®Google Scholar
• Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34(7):969–977.e2. doi:10.1016/j.cmet.2022.05.003.
   PubMed Web of Science ®Google Scholar
• Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C, Rehm J. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393(10190):2493–2502. doi:10.1016/S0140-6736(18)32744-2.
   PubMed Web of Science ®Google Scholar
• Arab JP, Diaz LA, Baeza N, Idalsoaga F, Fuentes-Lopez E, Arnold J, Ramirez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E. et al. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study. J Hepatol. 2021;75(5):1026–1033. doi:10.1016/j.jhep.2021.06.019.
   PubMed Web of Science ®Google Scholar
• Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572–1585. doi:10.1053/j.gastro.2011.09.002.
   PubMed Web of Science ®Google Scholar
• Szabo G. Gut–liver axis in alcoholic liver disease. Gastroenterology. 2015;148(1):30–36. doi:10.1053/j.gastro.2014.10.042.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009;50(3):538–547. doi:10.1016/j.jhep.2008.10.028.
   PubMed Web of Science ®Google Scholar
• Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Starkel P, Windey K, Tremaroli V, Backhed F, Verbeke K. et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci USA. 2014;111(42):E4485–E4493. doi:10.1073/pnas.1415174111.
   PubMed Web of Science ®Google Scholar
• Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, Schott E, Tsukamoto H, Nelson KE, Brenner DA, Schnabl B. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology. 2011;53(1):96–105. doi:10.1002/hep.24018.
   PubMed Web of Science ®Google Scholar
• Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000;32(5):742–747. doi:10.1016/S0168-8278(00)80242-1.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, Noble NA, Unser AB, Daita K, Fisher AR. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2014;60(5):940–947. doi:10.1016/j.jhep.2013.12.019.
   PubMed Web of Science ®Google Scholar
• Israelsen M, Alvarez-Silva C, Madsen BS, Hansen CD, Torp NC, Johansen S, Hansen JK, Lindvig KP, Insonere J, Riviere V. et al. Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver disease. Gut. 2023;73(6):1041–1044. doi:10.1136/gutjnl-2023-330360.
   Web of Science ®Google Scholar
• Xiang QW, Li MF, Wen JY, Ren FJ, Yang Z, Jiang XY, Chen Y. The bioactivity and applications of pomegranate peel extract: a review. J Food Biochem. 2022;46(7). doi:10.1111/jfbc.14105.
   Web of Science ®Google Scholar
• Heber D. Multitargeted therapy of cancer by ellagitannins. Cancer Lett. 2008;269(2):262–268. doi:10.1016/j.canlet.2008.03.043.
   PubMed Web of Science ®Google Scholar
• Sharifi-Rad J, Quispe C, Castillo CMS, Caroca R, Lazo-Velez MA, Antonyak H, Polishchuk A, Lysiuk R, Oliinyk P, De Masi L. et al. Ellagic acid: a review on its natural sources, chemical stability, and therapeutic potential. Oxid Med Cell Longev. 2022;2022:1–24. doi:10.1155/2022/3848084.
   Web of Science ®Google Scholar
• Andreux PA, Blanco-Bose W, Ryu D, Burdet F, Ibberson M, Aebischer P, Auwerx J, Singh A, Rinsch C. The mitophagy activator urolithin a is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab. 2019;1(6):595–603. doi:10.1038/s42255-019-0073-4.
   PubMedGoogle Scholar
• Cerda B, Periago P, Espin JC, Tomas-Barberan FA. Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds. J Agric Food Chem. 2005;53(14):5571–5576. doi:10.1021/jf050384i.
   PubMed Web of Science ®Google Scholar
• Selma MV, Beltran D, Garcia-Villalba R, Espin JC, Tomas-Barberan FA. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. Food Funct. 2014;5(8):1779–1784. doi:10.1039/c4fo00092g.
   PubMed Web of Science ®Google Scholar
• Espin JC, Larrosa M, Garcia-Conesa MT, Tomas-Barberan F. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med. 2013;2013(9):1–15. doi:10.1155/2013/270418.
   Google Scholar
• Ishimoto H, Shibata M, Myojin Y, Ito H, Sugimoto Y, Tai A, Hatano T. In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin a. Bioorg Med Chem Lett. 2011;21(19):5901–5904. doi:10.1016/j.bmcl.2011.07.086.
   PubMed Web of Science ®Google Scholar
• Cerdá B, Periago P, Espín JC, Tomás-Barberán FA. Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds. J Agric Food Chem. 2005;53(14):5571–5576. doi:10.1021/jf050384i.
   PubMed Web of Science ®Google Scholar
• Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, Hiwale AA, Saiyed T, Patel P, Vijay-Kumar M. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun. 2019;10(1):1–18. doi:10.1038/s41467-018-07859-7.
   PubMedGoogle Scholar
• Zhang C, Song YY, Yuan M, Chen L, Zhang QY, Hu JJ, Meng Y, Li S, Zheng GH, Qiu ZP. Ellagitannins-derived intestinal microbial metabolite urolithin a ameliorates fructose-driven hepatosteatosis by suppressing hepatic lipid metabolic reprogramming and inducing lipophagy. J Agric Food Chem. 2023;71(9):3967–3980. doi:10.1021/acs.jafc.2c05776.
   PubMed Web of Science ®Google Scholar
• Karim S, Madani B, Burzangi AS, Alsieni M, Bazuhair MA, Jamal M, Daghistani H, Barasheed MO, Alkreathy H, Khan MA. et al. Urolithin A’s antioxidative, anti-inflammatory, and antiapoptotic activities mitigate doxorubicin-induced liver injury in Wistar rats. Biomedicines. 2023;11(4):1125. doi:10.3390/biomedicines11041125.
   PubMed Web of Science ®Google Scholar
• Ryu D, Mouchiroud L, Andreux PA, Katsyuba E, Moullan N, Nicolet-Dit-Felix AA, Williams EG, Jha P, Lo Sasso G, Huzard D. et al. Urolithin a induces mitophagy and prolongs lifespan in C-elegans and increases muscle function in rodents. Nat Med. 2016;22(8):879–888. doi:10.1038/nm.4132.
   PubMed Web of Science ®Google Scholar
• Yang JP, Guo YQ, Henning SM, Chan B, Long JF, Zhong J, Acin-Perez R, Petcherski A, Shirihai O, Heber D. et al. Front cover: ellagic acid and its microbial metabolite urolithin a alleviate diet-induced insulin resistance in mice. Mol Nutr Food Res. 2020;64(19). doi:10.1002/mnfr.202070043.
   Web of Science ®Google Scholar
• Xia B, Shi XC, Xie BC, Zhu MQ, Chen Y, Chu XY, Cai GH, Liu M, Yang SZ, Mitchell GA. et al. Urolithin a exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice. PLOS Biol. 2020;18(3):e3000688. doi:10.1371/journal.pbio.3000688.
   PubMed Web of Science ®Google Scholar
• Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan-Olive MM, Caponio D, Dan X. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci. 2019;22(3):401–412. doi:10.1038/s41593-018-0332-9.
   PubMed Web of Science ®Google Scholar
• Zhao R, Long X, Yang J, Du L, Zhang X, Li J, Hou C. Pomegranate peel polyphenols reduce chronic low-grade inflammatory responses by modulating gut microbiota and decreasing colonic tissue damage in rats fed a high-fat diet. Food Funct. 2019;10(12):8273–8285. doi:10.1039/C9FO02077B.
   PubMed Web of Science ®Google Scholar
• Abdulrahman AO, Alzubaidi MY, Nadeem MS, Khan JA, Rather IA, Khan MI. Effects of urolithins on obesity-associated gut dysbiosis in rats fed on a high-fat diet. Int J Food Sci Nutr. 2021;72(7):923–934. doi:10.1080/09637486.2021.1886255.
   PubMed Web of Science ®Google Scholar
• Ma MX, Wang YX, Fan SQ, Huang YM, Su XR, Lu CY. Urolithin a alleviates colitis in mice by improving gut microbiota dysbiosis, modulating microbial tryptophan metabolism, and triggering AhR activation. J Agric Food Chem. 2023;71(20):7710–7722. doi:10.1021/acs.jafc.3c00830.
   PubMed Web of Science ®Google Scholar
• Romo-Vaquero M, Fernandez-Villalba E, Gil-Martinez A-L, Cuenca-Bermejo L, Carlos Espin J, Trinidad Herrero M, Victoria Selma M. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson’s patients. Food Funct. 2022;13(11):6306–6316. doi:10.1039/D2FO00552B.
   PubMed Web of Science ®Google Scholar
• Yu Z-H, Cao M, Wang Y-X, Yan S-Y, Qing L-T, Wu C-M, Li S, Li T-Y, Chen Q, Zhao J. Urolithin a attenuates Helicobacter pylori-induced damage in vivo. J Agric Food Chem. 2022;70(38):11981–11993. doi:10.1021/acs.jafc.2c03711.
   PubMedGoogle Scholar
• Longato L, Ripp K, Setshedi M, Dostalek M, Akhlaghi F, Branda M, Wands JR, de la Monte SM. Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease. Oxid Med Cell Longev. 2012;2012(2012):1–17. doi:10.1155/2012/479348.
   Google Scholar
• Tilg H, Adolph TE, Trauner M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab. 2022;34(11):1700–1718. doi:10.1016/j.cmet.2022.09.017.
   PubMed Web of Science ®Google Scholar
• Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, Ward DV, Grabherr F, Gerner RR, Pfister A. et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018;67(5):891–901. doi:10.1136/gutjnl-2016-313432.
   PubMed Web of Science ®Google Scholar
• Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65(12):2035–2044. doi:10.1136/gutjnl-2016-312729.
   PubMed Web of Science ®Google Scholar
• Wang LR, Fouts DE, Starkel P, Hartmann P, Chen P, Llorente C, DePew J, Moncera K, Ho SB, Brenner DA. et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe. 2016;19(2):227–239. doi:10.1016/j.chom.2016.01.003.
   PubMed Web of Science ®Google Scholar
• Villalobos-Labra R, Subiabre M, Toledo F, Pardo F, Sobrevia L. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity. Mol Aspects Med. 2019;66(0):49–61. doi:10.1016/j.mam.2018.11.001.
   PubMedGoogle Scholar
• Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900–917. doi:10.1016/j.cell.2010.02.034.
   PubMed Web of Science ®Google Scholar
• Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69(4):927–947. doi:10.1016/j.jhep.2018.06.008.
   PubMed Web of Science ®Google Scholar
• Haotian M, Chen SH, Xiong HY, Wang M, Hang W, Zhu XL, Zheng YB, Ge BS, Li RZ, Cui HL. Astaxanthin from Haematococcus pluvialis ameliorates the chemotherapeutic drug (doxorubicin) induced liver injury through the Keap1/Nrf2/HO-1 pathway in mice. Food Funct. 2020;11(5):4659–4671. doi:10.1039/C9FO02429H.
   PubMed Web of Science ®Google Scholar
• Wang BY, Gao XL, Liu BG, Li YC, Bai M, Zhang ZQ, Xu EP, Xiong ZE, Hu YL. Protective effects of curcumin against chronic alcohol-induced liver injury in mice through modulating mitochondrial dysfunction and inhibiting endoplasmic reticulum stress. Food Nutr Res. 2019;63(0):1–13. doi:10.29219/fnr.v63.3567.
   Google Scholar
• Gao R, Wang HT, Li T, Wang J, Ren ZT, Cai N, Ai HY, Li SS, Lu Y, Zhu YH. et al. Secreted MUP1 that reduced under ER stress attenuates ER stress induced insulin resistance through suppressing protein synthesis in hepatocytes. Pharmacol Res. 2023;187:106585. doi:10.1016/j.phrs.2022.106585.
   PubMed Web of Science ®Google Scholar
• Cao XL, Wan H, Wan H. Urolithin a induces protective autophagy to alleviate inflammation, oxidative stress, and endoplasmic reticulum stress in pediatric pneumonia. Allergol Immunopathol (Madr). 2022;50(6):147–153. doi:10.15586/aei.v50i6.743.
   PubMed Web of Science ®Google Scholar
• Zhang YZ, Aisker G, Dong HY, Halemahebai G, Zhang Y, Tian LA. Urolithin a suppresses glucolipotoxicity-induced ER stress and TXNIP/NLRP3/IL-1β inflammation signal in pancreatic β cells by regulating AMPK and autophagy. Phytomedicine. 2021;93:153741. doi:10.1016/j.phymed.2021.153741.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol. 2019;70(2):260–272. doi:10.1016/j.jhep.2018.10.019.
   PubMed Web of Science ®Google Scholar
• Lang S, Schnabl B. Microbiota and fatty liver disease—the known, the unknown, and the future. Cell Host Microbe. 2020;28(2):233–244. doi:10.1016/j.chom.2020.07.007.
   PubMed Web of Science ®Google Scholar
• Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146(6):1513–1524. doi:10.1053/j.gastro.2014.01.020.
   PubMed Web of Science ®Google Scholar
• Ferrere G, Wrzosek L, Cailleux F, Turpin W, Puchois V, Spatz M, Ciocan D, Rainteau D, Humbert L, Hugot C. et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol. 2017;66(4):806–815. doi:10.1016/j.jhep.2016.11.008.
   PubMed Web of Science ®Google Scholar
• Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY. et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5(1):141. doi:10.1186/s40168-017-0359-2.
   PubMed Web of Science ®Google Scholar
• Chen LY, Chu HK, Hu LL, Li ZL, Yang L, Hou XH. The role of NADPH oxidase 1 in alcohol-induced oxidative stress injury of intestinal epithelial cells. Cell Biol Toxicol. 2022;39(5):2345–2364. doi:10.1007/s10565-022-09725-1.
   PubMed Web of Science ®Google Scholar
• Wang K, Liao MF, Zhou N, Bao L, Ma K, Zheng ZY, Wang YJ, Liu C, Wang WZ, Wang J. et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 2019;26(1):222–235.e5. doi:10.1016/j.celrep.2018.12.028.
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhang RS, Mu Y, Song Y, Hao N, Wei YB, Wang QB, Mackay CR. Propionate ameliorates alcohol-induced liver injury in mice via the gut–liver axis: focus on the improvement of intestinal permeability. J Agric Food Chem. 2022;70(20):6084–6096. doi:10.1021/acs.jafc.2c00633.
   PubMed Web of Science ®Google Scholar
• Smirnova E, Puri P, Muthiah MD, Daitya K, Brown R, Chalasani N, Liangpunsakul S, Shah VH, Gelow K, Siddiqui MS. et al. Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity. Hepatology. 2020;72(1):271–286. doi:10.1002/hep.31178.
   PubMed Web of Science ®Google Scholar
• Xie GX, Zhong W, Zheng XJ, Li Q, Qiu YP, Li HK, Chen HY, Zhou ZX, Jia W. Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. J Proteome Res. 2013;12(7):3297–3306. doi:10.1021/pr400362z.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang XX, Zhu LL, Yang XL, He F, Wang T, Bao T, Lu HX, Wang H, Yang SQ. Inulin alleviates inflammation of alcoholic liver disease via SCFAs-inducing suppression of M1 and facilitation of M2 macrophages in mice. Int Immunopharmacol. 2020;78:78. doi:10.1016/j.intimp.2019.106062.
   Web of Science ®Google Scholar
• Du HX, Yue SY, Niu D, Liu C, Zhang LG, Chen J, Chen Y, Guan Y, Hua XL, Li C. et al. Gut microflora modulates Th17/Treg cell differentiation in experimental autoimmune prostatitis via the short-chain fatty acid propionate. Front Immunol. 2022;13:13. doi:10.3389/fimmu.2022.915218.
   Web of Science ®Google Scholar
• Christiansen CB, Gabe MBN, Svendsen B, Dragsted LO, Rosenkilde MM, Holst JJ. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. Am J Physiol-Gastr L. 2018;315(1):G53–G65. doi:10.1152/ajpgi.00346.2017.
   PubMed Web of Science ®Google Scholar
• Psichas A, Sleeth ML, Murphy KG, Brooks L, Bewick GA, Hanyaloglu AC, Ghatei MA, Bloom SR, Frost G. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes. 2015;39(3):424–429. doi:10.1038/ijo.2014.153.
   PubMed Web of Science ®Google Scholar
• Larraufie P, Martin-Gallausiaux C, Lapaque N, Dore J, Gribble FM, Reimann F, Blottiere HM. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Sci Rep. 2018;8(1):74. doi:10.1038/s41598-017-18259-0.
   PubMedGoogle Scholar
• Liu XN, Li X, Xia B, Jin X, Zou QH, Zeng ZH, Zhao WY, Yan SK, Li L, Yuan SF. et al. High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis. Cell Metab. 2021;33(5):923–938.e6. doi:10.1016/j.cmet.2021.02.002.
   PubMed Web of Science ®Google Scholar
• Leclercq S, Le Roy T, Furgiuele S, Coste V, Bindels LB, Leyrolle Q, Neyrinck AM, Quoilin C, Amadieu C, Petit G. et al. Gut microbiota-induced changes in β-hydroxybutyrate metabolism are linked to altered sociability and depression in alcohol use disorder. Cell Rep. 2020;33(2):108238. doi:10.1016/j.celrep.2020.108238.
   PubMed Web of Science ®Google Scholar